Evidence map›Paper›PMID 36571259›Full record

Trial reportUnited European gastroenterology journal2023

Real-time use of artificial intelligence (CADEYE) in colorectal cancer surveillance of patients with Lynch syndrome-A randomized controlled pilot trial (CADLY).

Robert Hüneburg, Karolin Bucksch, Friederike Schmeißer, Dominik Heling, Tim Marwitz, Stefan Aretz, Dominik J Kaczmarek, Glen Kristiansen, Oliver Hommerding, Christian P Strassburg and 2 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in United European gastroenterology journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 4 pooled it
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 4 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Artificial intelligence for cancer screening and surveillance.ESMO real world data and digital oncology · 2024
    Review
  16. Article
  17. UEG Journal's impact and vision for the future.United European gastroenterology journal · 2024
    Article
  18. Article
  19. Observational
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Robert HüneburgNational Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany.ORCID 0000-0001-9957-8299
Karolin BuckschUniversity of Leipzig, Institute for Medical Informatics, Statistics and Epidemiology, Leipzig, Germany.
Friederike SchmeißerNational Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany.
Dominik HelingNational Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany.
Tim MarwitzNational Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany.
Stefan AretzNational Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany.
Dominik J KaczmarekNational Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany.ORCID 0000-0003-0093-7832
Glen KristiansenNational Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany.
Oliver HommerdingNational Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany.
Christian P StrassburgNational Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany.
Christoph EngelUniversity of Leipzig, Institute for Medical Informatics, Statistics and Epidemiology, Leipzig, Germany.
Jacob NattermannNational Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany.
University Hospital Bonn · DELeipzig University · DEUniversity of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLynch syndrome (LS), an autosomal dominant disorder caused by pathogenic germline variants in DNA mismatch repair (MMR) genes, represents the most common hereditary colorectal cancer (CRC) syndrome. Lynch syndrome patients are at high risk of CRC despite regular endoscopic surveillance.

objectiveOur aim was to investigate the diagnostic performance of artificial intelligence (AI)-assisted colonoscopy in comparison to High-Definition white-light endoscopy (HD-WLE) for the first time.

methodsPatients ≥18 years with LS, with a pathogenic germline variant (MLH1, MHS2, MSH6), and at least one previous colonoscopy (interval 10-36 months) were eligible. Patients were stratified by previous CRC and affected MMR gene with a 1:1 allocation ratio (AI-assisted vs. HD white-light endoscopy) in this exploratory pilot trial.

resultsBetween Dec-2021 and Dec-2022, 101 LS patients were randomised and 96 patients were finally analyzed after exclusion of 5 patients due to insufficient bowel preparation. In the HD-WLE arm, adenomas were detected in 12/46 patients compared to 18/50 in the AI arm (26.1% [95% CI 14.3-41.1] vs. 36.0% [22.9-50.8]; p = 0.379). The use of AI-assisted colonoscopy especially increased detection of flat adenomas (Paris classification 0-IIb) (examinations with detected flat adenomas: 3/46 [6.5%] vs. 10/50 [20%]; p = 0.07; numbers of detected flat adenomas: 4/20 vs. 17/30, p = 0.018). The median withdrawal time did not differ significantly between HD-WLE and AI (14 vs. 15 min; p = 0.170).

conclusionWe here present first data suggesting that real-time AI-assisted colonoscopy is a promising approach to optimize endoscopic surveillance in LS patients, in particular to improve the detection of flat adenomas.

Indexed as

AdenomaColorectal Neoplasms, Hereditary NonpolyposisArtificial IntelligenceColonoscopyHumansPilot Projectsendoscopy

Identifiers

PMID36571259
PMCPMC9892476
OpenAlexW4312195782

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.